Motley Fool via Yahoo
3 Million Reasons Novo Nordisk Still Looks Like a Phenomenal Buy
Since the start of 2022, shares of the Danish healthcare giant have risen by 120%, far outstripping the S&P 500's return of just 8%. The company is a big name in diabetes care and weight loss ...
4 minutes ago